Neutrophil to lymphocyte ratio predicts appropriate therapy in idiopathic dilated cardiomyopathy patients with primary prevention implantable cardioverter defibrillator

References

1. ↵
   1. Bardy GH,
   2. Lee KL,
   3. Mark DB,
   4. Poole JE,
   5. Packer DL,
   6. Boineau R,
   7. et al.

   (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225–237.

   OpenUrlCrossRefPubMedWeb of Science
2. 1. Hua W,
   2. Niu H,
   3. Fan X,
   4. Ding L,
   5. Xu YZ,
   6. Wang J,
   7. et al.

   (2012) Group ICDS: Preventive effectiveness of implantable cardioverter defibrillator in reducing sudden cardiac death in the Chinese population: a multicenter trial of ICD therapy versus non-ICD therapy. J Cardiovasc Electrophysiol 1(Suppl):S5–S9.

   OpenUrl
3. 1. Moss AJ,
   2. Hall WJ,
   3. Cannom DS,
   4. Daubert JP,
   5. Higgins SL,
   6. Klein H,
   7. et al.

   (1996) Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 335:1933–1940.

   OpenUrlCrossRefPubMedWeb of Science
4. ↵
   1. Moss AJ,
   2. Zareba W,
   3. Hall WJ,
   4. Klein H,
   5. Wilber DJ,
   6. Cannom DS,
   7. et al.

   (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883.

   OpenUrlCrossRefPubMedWeb of Science
5. ↵
   1. Daubert JP,
   2. Zareba W,
   3. Cannom DS,
   4. McNitt S,
   5. Rosero SZ,
   6. Wang P,
   7. et al.

   (2008) Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 51:1357–1365.

   OpenUrlFREE Full Text
6. ↵
   1. Thavikulwat AC,
   2. Tomson TT,
   3. Knight BP,
   4. Bonow RO,
   5. Choudhury L

   (2016) Appropriate Implantable Defibrillator Therapy in Adults with Hypertrophic Cardiomyopathy. J Cardiovasc Electrophysiol 27:953–960.

   OpenUrl
7. ↵
   1. Poole JE,
   2. Johnson GW,
   3. Hellkamp AS,
   4. Anderson J,
   5. Callans DJ,
   6. Raitt MH,
   7. et al.

   (2008) Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 359:1009–1017.

   OpenUrlCrossRefPubMedWeb of Science
8. ↵
   1. Vollmann D,
   2. Luthje L,
   3. Vonhof S,
   4. Unterberg C

   (2005) Inappropriate therapy and fatal proarrhythmia by an implantable cardioverter-defibrillator. Heart rhythm 2:307–309.

   OpenUrlCrossRefPubMedWeb of Science
9. ↵
   1. Aribas A,
   2. Akilli H,
   3. Gul EE,
   4. Kayrak M,
   5. Demir K,
   6. Duman C,
   7. et al.

   (2013) Can neutrophil/lymphocyte ratio predict recurrence of non-valvular atrial fibrillation after cardioversion? Anadolu Kardiyol Derg 13:123–130.

   OpenUrlPubMed
10. 1. Kaya H,
    2. Ertas F,
    3. Islamoglu Y,
    4. Kaya Z,
    5. Atilgan ZA,
    6. Cil H,
    7. et al.

    (2014) Association between neutrophil to lymphocyte ratio and severity of coronary artery disease. Clin Appl Thromb Hemost 20:50–54.

    OpenUrlCrossRefPubMed
11. ↵
    1. Uthamalingam S,
    2. Patvardhan EA,
    3. Subramanian S,
    4. Ahmed W,
    5. Martin W,
    6. Daley M,
    7. et al.

    (2011) Utility of the neutrophil to lymphocyte ratio in predicting long-term outcomes in acute decompensated heart failure. Am J Cardiol 107:433–438.

    OpenUrlCrossRefPubMed
12. ↵
    1. Tamhane UU,
    2. Aneja S,
    3. Montgomery D,
    4. Rogers EK,
    5. Eagle KA,
    6. Gurm HS

    (2008) Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol 102:653–657.

    OpenUrlCrossRefPubMedWeb of Science
13. ↵
    1. Chatterjee S,
    2. Chandra P,
    3. Guha G,
    4. Kalra V,
    5. Chakraborty A,
    6. Frankel R,
    7. et al.

    (2011) Pre-procedural Elevated White Blood Cell Count and Neutrophil-Lymphocyte (N/L) Ratio are Predictors of Ventricular Arrhythmias During Percutaneous Coronary Intervention. Cardiovasc Hematol Disord Drug Targets 11:58–60.

    OpenUrl
14. ↵
    1. Gibson PH,
    2. Cuthbertson BH,
    3. Croal BL,
    4. Rae D,
    5. El-Shafei H,
    6. Gibson G,
    7. et al.

    (2010) Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 105:186–191.

    OpenUrlCrossRefPubMedWeb of Science
15. ↵
    1. Shao Q,
    2. Chen K,
    3. Rha SW,
    4. Lim HE,
    5. Li G,
    6. Liu T

    (2015) Usefulness of Neutrophil/Lymphocyte Ratio as a Predictor of Atrial Fibrillation: A Meta-analysis. Arch Med Res 46:199–206.

    OpenUrl
16. ↵
    1. McMurray JJ,
    2. Adamopoulos S,
    3. Anker SD,
    4. Auricchio A,
    5. Bohm M,
    6. Dickstein K,
    7. et al.

    (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33:1787–1847.

    OpenUrlCrossRefPubMedWeb of Science
17. ↵
    (2011) American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, et al. ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for Echocardiography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance American College of Chest Physicians. J Am Soc Echocardiogr 24:229–267.

    OpenUrlCrossRefPubMed
18. ↵
    1. Hogye M,
    2. Mandi Y,
    3. Csanady M,
    4. Sepp R,
    5. Buzas K

    (2004) Comparison of circulating levels of interleukin-6 and tumor necrosis factor-alpha in hypertrophic cardiomyopathy and in idiopathic dilated cardiomyopathy. Am J Cardiol 94:249–251.

    OpenUrlCrossRefPubMedWeb of Science
19. ↵
    1. Albert CM,
    2. Ma J,
    3. Rifai N,
    4. Stampfer MJ,
    5. Ridker PM

    (2002) Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation 105:2595–2599.

    OpenUrlAbstract/FREE Full Text
20. ↵
    1. Bruins P,
    2. te Velthuis H,
    3. Yazdanbakhsh AP,
    4. Jansen PG,
    5. van Hardevelt FW,
    6. de Beaumont EM,
    7. et al.

    (1997) Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 96:3542–3548.

    OpenUrlAbstract/FREE Full Text
21. ↵
    1. Kanoupakis EM,
    2. Manios EG,
    3. Kallergis EM,
    4. Mavrakis HE,
    5. Goudis CA,
    6. Saloustros IG,
    7. et al.

    (2010) Serum markers of collagen turnover predict future shocks in implantable cardioverter-defibrillator recipients with dilated cardiomyopathy on optimal treatment. J Am Coll Cardiol 55:2753–2759.

    OpenUrlFREE Full Text
22. ↵
    1. Levine YC,
    2. Rosenberg MA,
    3. Mittleman M,
    4. Samuel M,
    5. Methachittiphan N,
    6. Link M,
    7. et al.

    (2014) B-type natriuretic peptide is a major predictor of ventricular tachyarrhythmias. Heart Rhythm 11:1109–1116.

    OpenUrlCrossRefPubMed
23. ↵
    1. Streitner F,
    2. Kuschyk J,
    3. Veltmann C,
    4. Brueckmann M,
    5. Streitner I,
    6. Brade J,
    7. et al.

    (2007) Prospective study of interleukin-6 and the risk of malignant ventricular tachyarrhythmia in ICD-recipients--a pilot study. Cytokine 40:30–34.

    OpenUrlCrossRefPubMed
24. ↵
    1. Theuns DA,
    2. Smith T,
    3. Szili-Torok T,
    4. Muskens-Heemskerk A,
    5. Janse P,
    6. Jordaens L

    (2012) Prognostic role of high-sensitivity C-reactive protein and B-type natriuretic peptide in implantable cardioverter-defibrillator patients. Pacing Clin Electrophysiol 35:275–282.

    OpenUrlPubMed
25. ↵
    1. Flevari P,
    2. Theodorakis G,
    3. Leftheriotis D,
    4. Kroupis C,
    5. Kolokathis F,
    6. Dima K,
    7. et al.

    (2012) Serum markers of deranged myocardial collagen turnover: their relation to malignant ventricular arrhythmias in cardioverter-defibrillator recipients with heart failure. Am Heart J 164:530–537.

    OpenUrlCrossRefPubMedWeb of Science
26. ↵
    1. Cheng A,
    2. Zhang Y,
    3. Blasco-Colmenares E,
    4. Dalal D,
    5. Butcher B,
    6. Norgard S,
    7. et al.

    (2014) Protein biomarkers identify patients unlikely to benefit from primary prevention implantable cardioverter defibrillators: findings from the Prospective Observational Study of Implantable Cardioverter Defibrillators (PROSE-ICD). Circ Arrhythm Electrophysiol 7:1084–1091.

    OpenUrlAbstract/FREE Full Text
27. ↵
    1. Köklü E,
    2. Yüksel İÖ,
    3. Arslan Ş,
    4. Bayar N,
    5. Çağırcı G,
    6. Gencer ES,
    7. et al.

    (2016) Is Elevated Neutrophil-to-Lymphocyte Ratio a Predictor of Stroke in Patients with Intermediate Carotid Artery Stenosis? J Stroke Cerebrovasc Dis 25:578–584.

    OpenUrlCrossRefPubMed
28. ↵
    1. Lattanzi S,
    2. Cagnetti C,
    3. Provinciali L,
    4. Silvestrini M

    (2016) Neutrophil-to-Lymphocyte Ratio Predicts the Outcome of Acute Intracerebral Hemorrhage. Stroke 47:1654–1657.

    OpenUrlAbstract/FREE Full Text
29. ↵
    1. Rotzius P,
    2. Thams S,
    3. Soehnlein O,
    4. Kenne E,
    5. Tseng CN,
    6. Björkström NK,
    7. et al.

    (2010) Distinct infiltration of neutrophils in lesion shoulders in ApoE-/- mice. Am J Pathol 177:493–500.

    OpenUrlCrossRefPubMedWeb of Science
30. ↵
    1. Drechsler M,
    2. Megens RT,
    3. van Zandvoort M,
    4. Weber C,
    5. Soehnlein O

    (2010) Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation 122:1837–1845.

    OpenUrlAbstract/FREE Full Text
31. ↵
    1. Ndrepepa G,
    2. Braun S,
    3. Mehilli J,
    4. von Beckerath N,
    5. Schömig A,
    6. Kastrati A

    (2008) Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes. Eur J Clin Invest 38:90–96.

    OpenUrlCrossRefPubMedWeb of Science
32. ↵
    1. Leclercq A,
    2. Houard X,
    3. Philippe M,
    4. Ollivier V,
    5. Sebbag U,
    6. Meilhac O,
    7. et al.

    (2007) Involvement of intraplaque hemorrhage in atherothrombosis evolution via neutrophil protease enrichment. J Leukoc Biol 82:1420–1429.

    OpenUrlCrossRefPubMedWeb of Science
33. ↵
    1. Onsrud M,
    2. Thorsby E

    (1981) Influence of in vivo hydrocortisone on some human blood lymphocyte subpopulations. I. Effect on natural killer cell activity. Scand J Immunol 13:573–579.

    OpenUrlCrossRefPubMedWeb of Science
34. ↵
    1. Avci A,
    2. Alizade E,
    3. Fidan S,
    4. Yesin M,
    5. Guler Y,
    6. Kargin R,
    7. et al.

    (2014) Neutrophil/lymphocyte ratio is related to the severity of idiopathic dilated cardiomyopathy. Scand Cardiovasc J 48:202–208.

    OpenUrl
35. ↵
    1. Yildiz A,
    2. Yuksel M,
    3. Oylumlu M,
    4. Polat N,
    5. Akil MA,
    6. Acet H

    (2015) The association between the neutrophil/lymphocyte ratio and functional capacity in patients with idiopathic dilated cardiomyopathy. Anatol J Cardiol 15:13–17.

    OpenUrl
36. ↵
    1. Yildiz A,
    2. Oylumlu M,
    3. Yuksel M,
    4. Aydin M,
    5. Polat N,
    6. Acet H,
    7. et al.

    (2015) The Association Between the Neutrophil-to-Lymphocyte Ratio and the Presence of Ventricular Premature Contractions in Young Adults. Clin Appl Thromb Hemost 21:475–479.

    OpenUrlCrossRefPubMed
37. ↵
    1. Thune JJ,
    2. Pehrson S,
    3. Nielsen JC,
    4. Haarbo J,
    5. Videbæk L,
    6. Korup E,
    7. et al.

    (2016) Rationale, design, and baseline characteristics of the DANish randomized, controlled, multicenter study to assess the efficacy of Implantable cardioverter defibrillators in patients with non-ischemic Systolic Heart failure on mortality (DANISH). Am Heart J 179:136–141.

    OpenUrl